Port Erin Biopharma Investments Limited (LSE: PEBI), incorporated on 3 May 2011 under the law of the Isle of Man for the purposes of investing in the Biotechnology and Biopharmaceutical sector.  The Company's strategy is to create value for Shareholders through investing in companies that have the potential to generate substantial revenues through the development of biopharmaceutical drugs.  The Company's Non-Executive Chairman is Jim Mellon, who has had a successful career in the fund management industry.  The Company intends to co-invest wherever possible alongside Mr Mellon in investments that he has identified.

Agronomics

CPT Capital is an investment firm that invests in visionary founders. Their mission is to drive the food and materials technology revolution by replacing animals in the supply chain.

CPT Capital

New Agrarian

Siddhi Capital is the venture partner for convention-crushing food and beverage companies. It blends deep operating knowledge and expertise through its strategic partnership with Siddhi Ops, and smart capital to propel brands forward in the food and beverage marketplace.

Siddhi Capital

Thia Ventures is an Early-stage investor in one of the most dynamic and essential fields of current human endeavor.

Thia Ventures

8090 Industries is a venture capital firm that partners with global conglomerates to invest in the industrial sectors. Specific focus is on decarbonization, aerospace, defense and advanced manufacturing.

8090 Industries

Echo is a venture capital investment firm.

Echo

Liberation Labs

Liberation Labs is a biotech firm developing an industrial agricultural biotechnology system. It focuses on infrastructure that commercializes novel protein manufacturing at the scale. The company invests in infrastructure that commercializes protein manufacture at the market's size and cost structure, allowing biology innovators to compete with animal protein while also providing customers with access to nutritious foods.

Liberation Labs is a biomanufacturing company focused on providing precision fermentation solutions for bioproducts, including food and materials. The company’s flagship offering, the Bio platform, claims to offer cost-effective, high-yielding, and efficient precision fermentation operations to solve bottlenecks in producing novel proteins.

Empowering sustainable food innovation through food engineering tech

Alternative Ingredients

🎥Legacy US biomanufacturing network unfit for next wave of bioproducts, says Liberation Labs CEO

Liberation Labs is a biomanufacturing company focused on providing precision fermentation solutions for bioproducts, including food and materials. The company’s flagship offering, the Bio platform, claims to offer cost-effective, high-yielding, and efficient precision fermentation operations to solve bottlenecks in producing novel proteins.As of April 2024, the company was halfway through the construction schedule of its commercial-scale fermentation plant in Richmond, Indiana, which was slated to be operational in Q1 2025. The plant will have a 600,000 l capacity, expandable to an additional 4 million liters.Funding and financialsIn <a href="https://sp-edge.com/updates/28247">April 2024</a>, Agronomics, a VC firm focused on cellular agriculture and biomanufacturing, invested USD 10 million in the company. This was part of a USD 12.5 million funding round, which also saw participation from existing investor Siddhi Capital. The fresh capital was earmarked for the construction of its commercial facility.

<div>
 
 California Cultured is a producer of cocoa products such as cocoa powder, chocolate, cocoa butter, and flavanols using plant cell culture technology by taking biopsies from selected cacao plants. The company developed its research based on Criollo cacao varieties, fine-tuning cell lines for specific flavors. In August 2022, the company announced that it was working on the development of cell-cultured coffee.
 
 
 As of December 2022, the company was building its 12,100 sq m facility in West Sacramento and had begun building its pilot plant. As of July 2023, the company was finalizing production methods, with the aim of a commercial launch by 2025&ndash;2026, following FDA approval.
 
 
 Key customers and partnerships
 
 
 In 2022, California Cultured partnered with VTT, a Finnish national research institute, to develop cell lines for cell-cultured coffee. 
 &nbsp;In 
 <a href="https://sp-edge.com/updates">
 February 2023
 </a>
 , the company inked a 10-year commercial partnership with Japanese chocolate corporation Meiji to incorporate its cell-based cocoa into Meiji's products. This collaboration marked the first global use of cell-cultured chocolate.
 
 
 Funding and financials
 
 
 California Cultured received undisclosed investments from investment platforms focused on clean, lab-grown food such as CULT Food Science (February 2022) and Blue Horizon (March 2022). In October 2021, the company raised USD 4 million in seed funding led by Agronomics to expand its R&amp;D activities.
 
 
 
 .
 
</div>

California Cultured

<div>
 
 Nukoko is a UK-based company that produces 100% cocoa-free chocolate peanuts made from locally sourced fava beans using a biotransformation and precision fermentation process. It also uses a microbial library of cocoa flavors to match chocolate in terms of flavor, thickness, and texture.
 
 
 
 
 As of October 2023, the company had opened a limited product launch and sold out the first batch of cocoa-free chocolate nuts, with a full launch planned for 2024. The company claims to produce 90% less carbon emission per kg than conventional chocolate.&nbsp;
 
 
 
 
 Funding and financials
 
 
 
 
 In April 2023, Nukoko secured GBP 525,000 (~USD 637,500) in a pre-seed round from IndieBio to support product development. In September 2023, the company initiated its seed funding round.
 
 
 
</div>

Nukoko

<div>
 
 Win-Win (WNWN Food Labs prior to 
 <a href="https://sp-edge.com/updates/27014">
 February 2024
 </a>
 ) is a London-based producer of cocoa-free chocolate using plant-based ingredients such as grains/cereals and legumes through a proprietary fermentation process. The company's cocoa-free chocolate can be used in candy bars, confectionery, cookies, chocolate coatings, ice cream, and beverages. It claims to use 90% less water and emit 80%&ndash;90% less greenhouse gases than regular chocolate.
 
 
 In May 2022, Win-Win was operating on a lab scale, capable of producing between 300kg and 600 kg (~661 and 1,323 lbs) of chocolate per month. In November 2022, the company began expanding its facility in Hackney Wick, increasing its production space 8x. In November 2023, the company expanded its plant-based milk chocolate to bakeries, foodservice, confectionery groups, and CPG/FMCG companies 
 <a href="https://sp-edge.com/updates/24144">
 worldwide
 </a>
 .
 
 
 The company had previously introduced limited-edition cocoa-free products via D2C channels: dark chocolate thins at GBP 10 (~USD 13) per box (May 2022) and the Waim! Bar priced at GBP 8 (~USD 9) for a pack of three bars (September 2022). In March 2023, the company finalized the recipe and process for a line of milk chocolate products that are cocoa- and dairy-free and contain both oats and tiger nuts. The company also experimented with an alternative chocolate ice cream bar at the H&auml;agen-Dazs Start-Up Innovation Challenge in June 2023.
 
 
 Key customers and partnerships
 
 
 In September 2023, Win-Win partnered with the UK department store Fortnum &amp; Mason to showcase its cocoa-free chocolate and technology, including a demonstration and tasting during Fortnum's Harvest Week. In December 2022, the company partnered with Milan-based luxury gift service DLISH to include its specialty chocolate hazelnut gianduja, a northern Italian confection, in DLISH's holiday gifts. In December 2023, the company completed the 
 <a href="https://sp-edge.com/updates/24805">
 CoLab Tech accelerator
 </a>
 with Mondelēz International and showcased its cocoa-free chocolate bars, truffles, and coated biscuits at Mondelēz's North American headquarters.
 
 
 Funding and financials
 
 
 In February 2023, Win-Win raised GBP 4.5 million (~USD 5.6 million) in Series A funding to scale up manufacturing and increase headcount in anticipation of its UK retail launch.
 
 
 
</div>

Win-Win

<div>
 
 Planet A Foods is a Germany-based startup that makes cocoa-free chocolate ChoViva (formerly NoCoa/QOA) via precision fermentation of oats and sunflower seeds. It then uses proprietary micro-bacteria and flavor formation processes to create a vegan product that mimics the texture and flavor of chocolate. In addition to Germany, ChoViva focuses on Austria and Switzerland, with expansion plans to the US in 2024.
 
 
 Planet A Foods produces cocoa-free chocolates by blending cocoa-free ingredients: a cocoa powder substitute (ChoViva Concentrate) and a cocoa butter substitute (ChoViva Butter). ChoViva represents Planet Foods' debut cocoa-free chocolate product, created using Planet A Foods' cocoa concentrate alternative. The chocolate is produced in-house at Planet A&rsquo;s facility in the Czech Republic. As of October 2023, the ChoViva range included 21 products with prices ranging from EUR 0.5 to EUR 9.95 (~USD 0.53 to USD 10.48).
 
 
 Additionally, the company was in the process of developing its cocoa butter alternative through precision fermentation technology, using single-cell oils and fermentation byproducts. As of October 2023, the company was shipping this fat to early customers for R&amp;D purposes.
 
 
 The company asserts that its chocolate product could be 10x more sustainable, 20% cheaper, and emit about 92% less than conventional chocolate while also using 30% less sugar and 94% less water.
 
 
 Key customers and partnerships
 
 
 In April 2023, the company partnered with German online retailer Confiserie Seidl to launch ChoViva, its first sustainable chocolate line. The brand sees itself as a B2B player, after partnering with oat cereal maker K&ouml;lln on a new line of vegan mueslis using the company's cocoa-free chocolate in September 2023. In December 2023, ChoViva teamed up with 
 <a href="https://sp-edge.com/updates/24997">
 Lindt
 </a>
 to launch a special edition chocolate bar for Veganuary, named &quot;Soft &amp; Creamy Hazelnut.
 
 
 In 
 <a href="https://sp-edge.com/updates/26955">
 February 2024
 </a>
 , Planet A Foods partnered with REWE Group, Germany&rsquo;s second-largest supermarket chain, to supply ChoViva for REWE Group&rsquo;s own-label cocoa-free products.
 
 
 Funding and financials
 
 
 In its latest funding round in 
 <a href="https://sp-edge.com/updates/26176">
 February 2024
 </a>
 , the company raised USD 15.4 million in Series A funding led by World Fund, with participation from Omnes Capital, Cherry Ventures, Nucleus Capital, and others. The funds were earmarked for additional scientist hires to bolster its 50-person team in Germany to increase the production of cocoa butter and palm oil alternatives on an industrial scale.
 
 
 
</div>

Planet A Foods

<div>
 
 Atomo Coffee is a developer of beanless coffee that comes in two flavors: 1) regular beanless coffee with 100 mg of caffeine per serving made from date seeds, ramon seeds, sunflower seed extract, pea protein, millet, lemon, guava, and defatted fenugreek seeds and 2) decaffeinated (decaf) beanless coffee. The company claims to be the world's first beanless coffee maker.
 
 
 The company&rsquo;s products are available for retail purchase at 
 <a href="https://sp-edge.com/updates/23234">
 Gumption Coffee
 </a>
 in New York. In addition, the company began taking pre-orders for wholesale at a price of USD 20.99 per pound (as of October 2023).
 
 
 The company also plans to open a facility in March 2024 that can annually produce four million lbs of ground coffee, made from upcycled date pits (~80 million cups).
 
 
 Atomo's brews reportedly use 94% less water and produce 93% less carbon emissions than traditional coffee.
 
 
 Key customers and partnerships
 
 
 In July 2022, the company partnered with Minor Figures, a vegan products company, to launch the 8-ounce canned Oat Milk Latte, a beanless cold brew, one of Atomo's first focus products.
 
 
 Funding and financials
 
 
 In June 2022, the company raised USD 40 million in a Series A funding round for product development and to scale up manufacturing. In November 2023, the company secured an undisclosed multi-million dollar investment from Japanese beverage leader 
 <a href="https://sp-edge.com/updates/24577">
 Suntory Holdings
 </a>
 to strengthen its international distribution.
 
 
 
</div>

Atomo Coffee

Companies providing technology related to fortification, cell culture, and fermentation and those supplying equipment including bioreactors and fermenters for the production of novel foods

Companies offering salt substitutes to reduce sodium content in foods and beverages

Companies developing natural sweeteners and solutions to reduce sugar content in foods and beverages

Companies creating natural flavor, texture, and coloring ingredients from plant-based sources like seaweed and algae

Companies producing chocolate without cocoa using ingredients like oats, seeds, and cell-cultured cocoa

Companies making coffee substitutes from ingredients like barley, date seeds, and sunflower seeds

Companies offering plant-based alternatives to honey and nut spreads, addressing dietary restrictions and allergies

Companies producing cooking oils and fats through fermentation, cell-cultured and plant-based extraction processes

Companies developing protein ingredients via cell-culture or fermentation for dietary supplements and food production, excluding plant-based or cell-cultured meat

Transforms raw materials into novel, sustainable food products with minimal environmental impact

<div>
 Agronomics, a VC firm specialising in cellular agriculture and biomanufacturing, has invested USD 10 million in Liberation Labs as part of a USD 12.5 million funding round. The round also involved existing investor, Siddhi Capital, increasing the total fund raised by the company to USD 33.5 million. This is in addition to non-dilutive funding commitments worth USD 55 million.
 This new investment will feed into the ongoing construction of Liberation Labs' Bio3 manufacturing platform in Richmond, Indiana. Currently at mid-construction, the platform is expected to be functional by the first quarter of 2025, depending on the completion of its Series A fundraising round.
 Established in 2022, Liberation Labs focuses on eliminating common challenges in novel protein manufacturing and positioning itself as a go-to production partner in the industrial biotechnology industry. Its primary operations are centered around the Bio3 platform, which targets fermentation companies and offers a capacity of 600,000 liters, extendable to an extra 4 million liters.
</div>

Liberation Labs

EDGE Insights

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless